Literature DB >> 29892060

DNA repair processes are critical mediators of p53-dependent tumor suppression.

Ana Janic1,2, Liz J Valente1,2,3, Matthew J Wakefield1,4, Leon Di Stefano1, Liz Milla1,2, Stephen Wilcox1,2, Haoyu Yang1,2,5, Lin Tai1, Cassandra J Vandenberg1,2, Andrew J Kueh1,2, Shinsuke Mizutani1,2, Margs S Brennan1,2, Robyn L Schenk1,2, Lisa M Lindqvist1,2, Anthony T Papenfuss1,2,6, Liam O'Connor1,2, Andreas Strasser7,8, Marco J Herold1,2.   

Abstract

It has long been assumed that p53 suppresses tumor development through induction of apoptosis, possibly with contributions by cell cycle arrest and cell senescence1,2. However, combined deficiency in these three processes does not result in spontaneous tumor formation as observed upon loss of p53, suggesting the existence of additional mechanisms that are critical mediators of p53-dependent tumor suppression function3-5. To define such mechanisms, we performed in vivo shRNA screens targeting p53-regulated genes in sensitized genetic backgrounds. We found that knockdown of Zmat3, Ctsf and Cav1, promoted lymphoma/leukemia development only when PUMA and p21, the critical effectors of p53-driven apoptosis, cell cycle arrest and senescence, were also absent. Notably, loss of the DNA repair gene Mlh1 caused lymphoma in a wild-type background, and its enforced expression was able to delay tumor development driven by loss of p53. Further examination of direct p53 target genes implicated in DNA repair showed that knockdown of Mlh1, Msh2, Rnf144b, Cav1 and Ddit4 accelerated MYC-driven lymphoma development to a similar extent as knockdown of p53. Collectively, these findings demonstrate that extensive functional overlap of several p53-regulated processes safeguards against cancer and that coordination of DNA repair appears to be an important process by which p53 suppresses tumor development.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29892060     DOI: 10.1038/s41591-018-0043-5

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  56 in total

1.  p53 regulates CD46 expression and measles virus infection in myeloma cells.

Authors:  Anne Lok; Geraldine Descamps; Benoit Tessoulin; David Chiron; Marion Eveillard; Catherine Godon; Yannick Le Bris; Astrid Vabret; Celine Bellanger; Laurent Maillet; Sophie Barillé-Nion; Marc Gregoire; Jean-François Fonteneau; Steven Le Gouill; Philippe Moreau; Frederic Tangy; Martine Amiot; Agnes Moreau-Aubry; Catherine Pellat-Deceunynck
Journal:  Blood Adv       Date:  2018-12-11

Review 2.  Context is everything: extrinsic signalling and gain-of-function p53 mutants.

Authors:  Ivano Amelio; Gerry Melino
Journal:  Cell Death Discov       Date:  2020-03-23

3.  CRISPR/Cas9 and p53: An Odd Couple Requiring Relationship Management.

Authors:  Seppo Ylä-Herttuala
Journal:  Mol Ther       Date:  2018-11-16       Impact factor: 11.454

Review 4.  Genetics of MDS.

Authors:  Seishi Ogawa
Journal:  Blood       Date:  2019-01-22       Impact factor: 22.113

5.  Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program.

Authors:  Kathryn T Bieging-Rolett; Alyssa M Kaiser; David W Morgens; Anthony M Boutelle; Jose A Seoane; Eric L Van Nostrand; Changyu Zhu; Shauna L Houlihan; Stephano S Mello; Brian A Yee; Jacob McClendon; Sarah E Pierce; Ian P Winters; Mengxiong Wang; Andrew J Connolly; Scott W Lowe; Christina Curtis; Gene W Yeo; Monte M Winslow; Michael C Bassik; Laura D Attardi
Journal:  Mol Cell       Date:  2020-11-05       Impact factor: 17.970

6.  A Dedicated Evolutionarily Conserved Molecular Network Licenses Differentiated Cells to Return to the Cell Cycle.

Authors:  Zhi-Feng Miao; Mark A Lewis; Charles J Cho; Mahliyah Adkins-Threats; Dongkook Park; Jeffrey W Brown; Jing-Xu Sun; Joseph R Burclaff; Susan Kennedy; Jianyun Lu; Marcus Mahar; Ilja Vietor; Lukas A Huber; Nicholas O Davidson; Valeria Cavalli; Deborah C Rubin; Zhen-Ning Wang; Jason C Mills
Journal:  Dev Cell       Date:  2020-08-07       Impact factor: 12.270

7.  Zmat3 splices together p53-dependent tumor suppression.

Authors:  Kathryn T Bieging-Rolett; Laura D Attardi
Journal:  Mol Cell Oncol       Date:  2021-04-29

8.  P53 orchestrates a complex symphony of cellular processes during oncosuppression.

Authors:  Liz J Valente; Laura D Attardi
Journal:  Mol Cell Oncol       Date:  2021-01-11

Review 9.  Life and Death Decision-Making by p53 and Implications for Cancer Immunotherapy.

Authors:  Yong Liu; Patrick L Leslie; Yanping Zhang
Journal:  Trends Cancer       Date:  2020-11-13

10.  DDIT4 Licenses Only Healthy Cells to Proliferate During Injury-induced Metaplasia.

Authors:  Zhi-Feng Miao; Jing-Xu Sun; Mahliyah Adkins-Threats; Min-Jiao Pang; Jun-Hua Zhao; Xin Wang; Kai-Wen Tang; Zhen-Ning Wang; Jason C Mills
Journal:  Gastroenterology       Date:  2020-09-19       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.